Suppr超能文献

钒化合物对大鼠实验性糖尿病中钙调蛋白活性的影响。

Effect of vanadium compounds on calmodulin activity in experimental diabetes in rats.

作者信息

Aktan F, Nebioglu S

机构信息

Department of Biochemistry, Ankara University, Faculty of Pharmacy, Turkey.

出版信息

Can J Physiol Pharmacol. 1994 Jul;72(7):753-8. doi: 10.1139/y94-107.

Abstract

Vanadate and vanadyl have been reported to have insulin-like properties and have recently been demonstrated to be beneficial in the treatment of diabetic animals. In this study, we determined whether vanadium ions mimic the effect of insulin on calmodulin activity of liver and adipose tissues in streptozotocin-induced diabetic rats and examined their effect with respect to concentration and time. Calmodulin activities in the hormone-sensitive tissues decreased in diabetes and returned to normal after sodium metavanadate or vanadyl sulfate treatment for 3 weeks (0.2, 0.4, and 0.8 mg/mL in drinking water). These results demonstrate that V5+ and V4+ forms of vanadium can restore the activity of calmodulin in experimental diabetes induced by streptozotocin.

摘要

据报道,钒酸盐和氧钒根离子具有胰岛素样特性,并且最近已证明它们对糖尿病动物的治疗有益。在本研究中,我们确定钒离子是否模拟胰岛素对链脲佐菌素诱导的糖尿病大鼠肝脏和脂肪组织钙调蛋白活性的影响,并研究了其浓度和时间效应。糖尿病时,激素敏感组织中的钙调蛋白活性降低,用偏钒酸钠或硫酸氧钒(饮用水中浓度为0.2、0.4和0.8 mg/mL)治疗3周后恢复正常。这些结果表明,V5+和V4+形式的钒可以恢复链脲佐菌素诱导的实验性糖尿病中钙调蛋白的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验